You just read:

First Patients Enrolled into European Phase III Programme for Potential First in Class Oral Treatment for Anaemia Associated with Chronic Kidney Disease (CKD)

News provided by

Astellas Pharma Europe Ltd

17 Mar, 2014, 11:32 GMT